- Home
- Personal stories
Personal stories
The power of prioritizing your vision
The idea of sight loss can be scary—but prompt diagnosis by an eye specialist can, in many cases, help preserve vision. For Healthy Vision Month, let these two patient stories inspire you to take action and schedule your checkup.
How drones are being used to deliver lifesaving HIV drugs to remote areas of the world
Normally, in this part of Uganda, medication is delivered by boat—a slow, difficult process. But now a new Johnson & Johnson-supported program is using drones that can serve 20 landing sites across five islands, reaching more than 3,700 people in a single day.
What you need to know about Johnson & Johnson’s 2021 second-quarter earnings
Check out this infographic breakdown of the company’s second-quarter 2021 performance, with key highlights from its Pharmaceutical, Consumer Health and Medical Device businesses.
“1.5 million children are living with HIV in sub-Saharan Africa. I’m one of the doctors treating these young patients every day”
A relaunched Johnson & Johnson partnership will help ensure that many young patients get lifesaving access to HIV medicines. Meet a doctor in Kenya who explains why the program is so crucial.
3 cutting-edge eye lenses designed to help improve how you see
Multifocal contacts based on your pupil size. Intraocular lenses that adapt to our digital world. These are just some of the new Johnson & Johnson advances poised to change the future of vision care.
“How Johnson & Johnson helped us adopt 11 children”
In honor of Father’s Day, Cameron Bernadsky talks about the joys of having a large family, the power of a supportive workplace and what parenting in a pandemic really looks like.
How Johnson & Johnson has pioneered in the battle against HIV/AIDS
For World AIDS Day, we look at the groundbreaking strides the company has made—and continues to make—toward a world without the disease.
What to know about HDFN, a serious blood disorder in babies, including a possible new treatment
Severe cases of hemolytic disease of the fetus and newborn can be deadly in infants. That’s why Johnson & Johnson is passionate about investigating a promising option for treating the disorder.
The quest to help patients with a deadly type of lung cancer
Despite obstacles and setbacks, these researchers vowed to never give up working to develop a new treatment for non-small cell lung cancer. For Lung Cancer Awareness Month, they share their journey.